Skip to main content

Recombinant Mouse FCRN Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 6775-FC

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
6775-FC-050

Key Product Details

Source

NS0

Accession #

Conjugate

Unconjugated

Applications

Bioactivity

Product Specifications

Source

Mouse myeloma cell line, NS0-derived mouse FCRN protein
Ser22-Ser301, with a C-terminal 6-His tag

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Ser22

Predicted Molecular Mass

32.3 kDa

SDS-PAGE

45-47 kDa, reducing conditions

Activity

Measured by its binding ability in a functional ELISA.
When Recombinant Mouse FCRN is immobilized at 0.5 μg/mL (100 μL/well), the concentration of human IgG that produces 50% of the optimal binding response is found to be approximately 2-10 μg/mL.

Reviewed Applications

Read 2 reviews rated 5 using 6775-FC in the following applications:

Formulation, Preparation and Storage

6775-FC
Formulation Lyophilized from a 0.2 μm filtered solution in PBS, NaCl and Triton
Reconstitution
Reconstitute at 250 μg/mL in PBS.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: FCRN

The neonatal Fc receptor (FCRN) is an approximately 45 kDa transmembrane glycoprotein with structural homology to MHC class I proteins. It is widely expressed in endothelial and epithelial cells and plays an important role in IgG homeostasis (1). Mature mouse FCRN consists of a 276 amino acid (aa) extracellular domain (ECD) with two N-terminal alpha domains, one alpha3/immunoglobulin-like domain, a 24 aa transmembrane segment, and a 44 aa cytoplasmic domain (2). Within the ECD, mouse FCRN shares 69% and 91% aa sequence identity with human and rat FCRN, respectively. Mouse FCRN binds with high affinity to IgG from mouse, human, rat, rabbit, guinea pig, bovine, and sheep, while human FCRN binds IgG with significantly lower affinity and is much more restricted in terms of species recognition (3). It does not bind the structurally related chicken IgY (4). FCRN additionally binds to albumin, and both it and IgG are bound at pH 5.0 but not at pH 8.0 (2, 5). FCRN associates noncovalently with beta 2-Microglobulin, and this interaction is important for the intracellular trafficking of FCRN (6 ‑ 9). FCRN cycles between the plasma membrane and acidified intracellular compartments of endothelial cells and epithelial cells (4, 7). It binds endocytosed IgG and albumin in the low pH vesicles and transports them to the plasma membrane for extracellular release at higher pH. This protects IgG and albumin from lysosomal degradation and helps maintain the circulating levels of both proteins (4, 5). This mechanism is involved in the bidirectional transport of IgG across epithelial and endothelial barriers including neonatal IgG absorption in the intestine and fetal uptake of maternal antibodies through the placenta (4, 7, 10, 11). In the kidney, FCRN recycles albumin to the serum but removes IgG from the glomular basement membrane and promotes its excretion into the urine (12, 13). FCRN is also expressed in neutrophils and myeloid antigen presenting cells (6, 14, 15). It can enhance IgG-mediated phagocytosis and antigen presentation by these cells, but it promotes the degradation of opsonizing IgG rather than returning it to the circulation (14, 15).

References

  1. Baker, K. et al. (2009) Semin. Immunopathol. 31:223.
  2. Ahouse, J.J. et al. (1993) J. Immunol. 151:6076.
  3. Ober, R.J. et al. (2001) Int. Immunol. 13:1551.
  4. Dickinson, B.L. et al. (1999) J. Clin. Invest. 104:903.
  5. Chaudhury, C. et al. (2003) J. Exp. Med. 197:315.
  6. Simister, N.E. and K.E. Mostov (1989) Nature 337:184.
  7. Kobayashi, N. et al. (2002) Am. J. Physiol. Renal Physiol. 282:F358.
  8. Praetor, A. and W. Hunziker (2002) J. Cell Sci. 115:2389.
  9. Zhu, X. et al. (2001) J. Immunol. 166:3266.
  10. Spiekermann, G.M. et al. (2002) J. Exp. Med. 196:303.
  11. Firan, M. et al. (2001) Int. Immunol. 13:993.
  12. Sarav, M. et al. (2009) J. Am. Soc. Nephrol. 20:1941.
  13. Akilesh, S. et al. (2008) Proc. Natl. Acad. Sci. 105:967.
  14. Vidarsson, G. et al. (2006) Blood 108:3573.
  15. Qiao, S.-W. et al. (2008) Proc. Natl. Acad. Sci. 105:9337.

Long Name

Neonatal Fc Receptor

Alternate Names

FCGRT

Entrez Gene IDs

2217 (Human); 14132 (Mouse); 29558 (Rat); 102128913 (Cynomolgus Monkey)

Gene Symbol

FCGRT

Additional FCRN Products

Product Documents for Recombinant Mouse FCRN Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Mouse FCRN Protein, CF

For research use only

Loading...
Loading...
Loading...